journal article·2025-09Open access

Recent advances in the ESIPT-based drug delivery systems for targeted diseases treatment

Hossein Roohi, Mina Rouhi

Dyes and Pigments· Volume 240

Abstract

Drug delivery systems (DDSs) signify a revolutionary approach in contemporary therapeutics, aimed at maximizing drug effectiveness through advanced technological methods. The key goals of DDSs include enhancing therapeutic efficacy, reducing systemic side effects , improving drug bioavailability, and controlled drug release . Among the several stimuli-responsive DDSs, excited-state intramolecular proton transfer (ESIPT)-based DDSs are indeed garnering significant interest in the field of medicine and drug delivery. The unique characteristics of the ESIPT-based molecules such as large Stokes shifts, dual emission, and environment-sensitive fluorescence enable real-time monitoring of drug release, precise spatiotemporal control, and the integration of therapeutic and diagnostic functions. Recent advances have demonstrated the remarkable potential of ESIPT-based systems in developing intelligent drug delivery platforms. By harnessing photophysical phenomena such as aggregation-induced emission (AIE) and ESIPT, researchers have developed sophisticated molecular systems that offer controlled drug release mechanisms, real-time fluorescence monitoring, enhanced cellular imaging capabilities and targeted therapeutic interventions. This review article seeks to offer an overview of recent advancements in ESIPT-based DDSs, highlighting their distinctive properties, diverse applications, and future potential. By exploring the fundamental principles of ESIPT and its integration with state-of-the-art technologies, we aim to stimulate further research and innovation in this promising field.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Brain-targeting drug delivery systems: the state of the art in treatment of glioblastoma10.1016/j.mtbio.2025.101443 ↗
2. Recent breakthroughs in drug delivery systems for targeted cancer therapy: an overview10.55705/cmbr.2025.456494.1246 ↗
3. Controlled dual drug delivery system based on gelatin electrospinning membranes for wound healing promotion10.1016/j.ijbiomac.2024.138720 ↗
4. Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward10.1039/D4NR03611E ↗
5. Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery10.1021/acsnano.4c09566 ↗
6. A comprehensive review on nanoparticles as drug delivery system and their role for management of hypertension10.2174/0113892010291414240322112508 ↗
7. Design, evaluation, and in Vitro–In vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide10.1016/j.jconrel.2025.01.013 ↗
8. Recent advancements on self‐immolative system based on dynamic covalent bonds for delivering heterogeneous payloads10.1002/adhm.202300138 ↗
9. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments10.1016/j.addr.2023.114773 ↗
10. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment10.1016/j.cclet.2022.05.032 ↗
11. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity10.1016/j.jconrel.2015.12.006 ↗
12. Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery10.1016/j.ejps.2014.05.021 ↗
13. Controlled release of doxorubicin from pH-responsive microgels10.1016/j.actbio.2012.09.019 ↗
14. Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells10.1016/j.carbpol.2011.10.040 ↗
15. Cationic poly-llysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo10.1021/nn305860k ↗
16. Synthesis and characterization of poly (N-isopropylacrylamide)-g-carboxymethyl chitosan copolymer-based doxorubicin-loaded polymeric nanoparticles for thermoresponsive drug release10.1007/s00396-015-3804-4 ↗
17. Controlled release of doxorubicin from thermosensitive poly (organophosphazene) hydrogels10.1016/j.ijpharm.2006.03.032 ↗
18. Thermally controlled release of anticancer drug from self-assembled γ-substituted amphiphilic poly (ε-caprolactone) micellar nanoparticles10.1021/bm300823y ↗
19. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors10.1016/j.jconrel.2016.06.035 ↗
20. pH‐and NIR light‐responsive micelles with hyperthermia‐triggered tumor penetration and cytoplasm drug release to reverse doxorubicin resistance in breast cancer10.1002/adfm.201404484 ↗
21. A water-soluble, green-light triggered, and photo-calibrated nitric oxide donor for biological applications10.1021/acs.bioconjchem.7b00821 ↗
22. Novel approach of using near-infrared responsive PEGylated gold nanorod coated poly (l-lactide) microneedles to enhance the antitumor efficiency of docetaxel-loaded MPEG-PDLLA micelles for treating an A431 tumor10.1021/acsami.7b03604 ↗
23. Light-and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier10.1002/chem.201002960 ↗
24. Visible light-driven photogeneration of hydrogen sulfide10.1039/C7CC06990A ↗
25. Initial investigation of acoustic droplet vaporization for occlusion in canine kidney10.1016/j.ultrasmedbio.2010.06.020 ↗
26. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets10.1016/j.colsurfb.2017.01.051 ↗
27. Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles10.1039/C8CC05504A ↗
28. MMP-2-sensitive HA end-conjugated poly (Amidoamine) dendrimers via click reaction to enhance drug penetration into solid tumor10.1021/acsami.7b10098 ↗
29. MMP-9 triggered self-assembly of doxorubicin nanofiber depots halts tumor growth10.1016/j.biomaterials.2016.04.039 ↗
30. siRNA delivery systems for cancer treatment10.1016/j.addr.2009.04.018 ↗
31. Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model10.1016/j.jconrel.2014.03.016 ↗
32. Polylactic acid (PLA) controlled delivery carriers for biomedical applications10.1016/j.addr.2016.06.018 ↗
33. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery10.1016/j.biomaterials.2013.10.057 ↗
34. Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy10.1002/adma.201003763 ↗
35. Magnetoliposomes as potential carriers of doxorubicin to tumours10.1002/chem.201602809 ↗
36. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals10.1021/nn103415x ↗
37. High-contrast in vivo visualization of microvessels using novel FeCo/GC magnetic nanocrystals10.1002/mrm.22343 ↗
38. Rapid photolytic release of adenosine 5'-triphosphate from a protected analog: utilization by the sodium: potassium pump of human red blood cell ghosts10.1021/bi00603a020 ↗
39. New photoactivated protecting groups. 6. p-Hydroxyphenacyl: a phototrigger for chemical and biochemical Probes1, 210.1021/ja9635589 ↗
40. Photocaging of single and dual (similar or different) carboxylic and amino acids by acetyl carbazole and its application as dual drug delivery in cancer therapy10.1021/acs.joc.6b02152 ↗
41. Near-infrared light-triggered drug-delivery vehicle for mitochondria-targeted chemo-photothermal therapy10.1021/am5000883 ↗
42. Coumarin–benzothiazole–chlorambucil (Cou–Benz–Cbl) conjugate: an ESIPT based pH sensitive photoresponsive drug delivery system10.1039/C4TB02081B ↗
43. NIR-Responsive carboxymethyl-cellulose hydrogels containing thioketal-linkages for on-demand drug delivery system10.1016/j.ijbiomac.2024.129549 ↗
44. Light responsive hydrogels for controlled drug delivery10.3389/fbioe.2022.1075670 ↗
45. Recent advances in light-responsive on-demand drug-delivery systems10.4155/tde-2016-0060 ↗
46. Light triggered uncaging of hydrogen sulfide (H 2S) with real-time monitoring10.1039/C8CC01172A ↗
47. ESIPT-, AIE-, and AIE+ ESIPT-based light-activated drug delivery systems and bioactive donors for targeted disease treatment10.1021/acs.jmedchem.2c01466 ↗
48. Peptide-based cancer-targeted DDS and molecular imaging10.1248/cpb.c17-00098 ↗
49. Visualization of drug delivery processes using AIEgens10.1039/C6SC05421H ↗
50. Advanced static and dynamic fluorescence microscopy techniques to investigate drug delivery systems10.3390/pharmaceutics13060861 ↗
51. Recent advances in interventional fluorescence imaging: Toward the precise visualization of transarterial mini-invasive delivery systems10.1021/accountsmr.2c00195 ↗
52. Fluorescence imaging as a tool in preclinical evaluation of polymer-based nano-DDS systems intended for cancer treatment10.3390/pharmaceutics11090471 ↗
53. Recent advancements over the past four years in ESIPT-Based organic lasers10.1016/j.dyepig.2025.112721 ↗
54. ESIPT‐based AIE luminogens: design strategies, applications, and mechanisms10.1002/agt2.160 ↗
55. White light employing luminescent engineered large (mega) stokes shift molecules: a review10.1039/D1RA00129A ↗
56. Organic near‐infrared luminescent materials based on excited state intramolecular proton transfer process10.1002/cjoc.202200313 ↗
57. A multifunctional AIEgen with high cell-penetrating ability for intracellular fluorescence assays, imaging and drug delivery10.1039/C9QM00089E ↗
58. A novel fluorophore based on the coupling of AIE and ESIPT mechanisms and its application in biothiol imaging10.1039/C7TB02076G ↗
59. Novel quercetin aggregation‐induced emission luminogen (AIEgen) with excited‐state intramolecular proton transfer for in vivo bioimaging
60. Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents10.1039/C8CS00185E ↗
61. An ESIPT-Based NIR-Fluorescent probe for exosome labeling and in situ imaging10.1016/j.cclet.2023.108273 ↗
62. An ESIPT-Based fluorescent probe for aqueous Cu2+ detection through strip, nanofiber and living cells10.3390/molecules28093725 ↗
63. Highly sensitive and rapid detection of hypochlorous acid in aqueous media and its bioimaging in live cells and zebrafish using an ESIPT-Driven mycophenolic acid-based fluorescent probe10.1039/D3AN01340E ↗
64. AI‐Powered mining of highly customized and superior ESIPT‐Based fluorescent probes
65. An ESIPT fluorescent probe for ultrarapid HClO detection during reagent-stimulated oxidative stress in cells and zebrafish10.1016/j.snb.2022.132545 ↗
66. Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents10.1039/C8CS00185E ↗
67. Dynamic time‐dependent emission in solution and stable dual emission in solid matrix exhibited by a single‐component fluorescence system10.1002/adfm.202314093 ↗
68. Artificial light-harvesting nanoparticles based on a tripodal fluorescence sensor mediated by multiple luminescence mechanisms10.1039/D3SD00297G ↗
69. ESIPT-Based probes for cations, anions and neutral species: recent progress, multidisciplinary applications and future perspectives10.1039/D3AY01249B ↗
70. Recent progress in ESIPT-Based fluorescent chemosensors for detection of Zn2+, Mg2+ and Cu2+
71. A highly selective ESIPT-mechanism-based, ratiometric fluorescent sensor for zinc ions10.1016/j.dyepig.2024.112547 ↗
72. Uncovering integrated dual‐state ESIPT‐Conductivity, redox‐capacity, and opto‐electronic responses toward Hg (II)/cr (III) of aliphatic fluorescent polymers10.1002/marc.202400677 ↗
73. Novel spiropyran fluorescent probes based on ESIPT and ICT: ph response & cyanide detection10.1016/j.molstruc.2024.140429 ↗
74. Novel spiropyran fluorescent probes based on ESIPT and ICT: ph response & cyanide detection10.1016/j.molstruc.2024.140429 ↗
75. Novel perylene diimide–benzothaizole hybrid: a reaction‐based probe for the detection and discrimination of H2S, cys and DTT10.1002/bio.70078 ↗
76. Photoconductance induced by excited‐state intramolecular proton transfer (ESIPT) in single‐molecule junctions10.1002/adma.202413529 ↗
77. Cascaded excited‐state intramolecular proton transfer towards near‐infrared organic lasers beyond 850 nm10.1002/ange.202016786 ↗
78. Excited-state intramolecular proton transfer (ESIPT) based metal–organic supramolecular optical materials: energy transfer mechanism and luminescence regulation strategy10.1021/accountsmr.3c00139 ↗
79. Solid-state emitters presenting a modular excited-state proton transfer (ESIPT) process: recent advances in dual-state emission and lasing applications10.1039/D3CP00938F ↗
80. Deep-red and near-infrared organic lasers based on centrosymmetric molecules with excited-state intramolecular double proton transfer activity10.29026/oea.2023.230007 ↗
81. Deepening insights into near‐infrared excited‐state intramolecular proton transfer lasing: the charm of resonance‐assisted hydrogen bonds10.1002/adfm.202204129 ↗
82. A dual-response fluorescent hemicyanine probe for the detection of mitochondrial hypochlorite and viscosity based on ESIPT/AIE and TICT10.1016/j.snb.2024.136695 ↗
83. “AIE+ ESIPT” based naphthothiazole fluorescent probes for live cell imaging10.1016/j.molstruc.2024.139542 ↗
84. Visible-to-NIR-light activated release: from small molecules to nanomaterials10.1021/acs.chemrev.0c00663 ↗
85. Developing an ESIPT-Based ratiometric fluorescent probe with fast-response for cellular imaging of hydrogen sulfide10.1016/j.microc.2024.111143 ↗
86. Environment activatable nanoprodrug: two-step surveillance in the anticancer drug release10.1021/acsami.7b05132 ↗
87. Photoactive assemblies of organic compounds and biomolecules: Drug–Protein supramolecular systems10.1039/C3CS60413F ↗
88. A fast and cost-effective methodology for Fonsecaea pedrosoi ATCC46428 staining using ESIPT fluorescent dyes10.1016/j.jphotobiol.2010.03.007 ↗
89. Novel ESIPT fluorescent benzazolyl-4-quinolones: synthesis, spectroscopic characterization and photophysical properties10.1016/j.dyepig.2009.07.010 ↗
90. An understanding of the modulation of photophysical properties of curcumin inside a micelle formed by an ionic liquid: a new possibility of tunable drug delivery system10.1021/jp211242c ↗
91. Fluorescence imaging as a tool in preclinical evaluation of polymer-based nano-DDS systems intended for cancer treatment10.3390/pharmaceutics11090471 ↗
92. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems10.1016/j.addr.2018.12.004 ↗
93. Fluorescence imaging of pathophysiological microenvironments10.1039/D1CS00083G ↗
94. Small-molecule fluorescence-based probes for interrogating major organ diseases10.1039/D0CS01183E ↗
95. Fluorescent nanosystems for drug tracking and theranostics: recent applications in the ocular field10.3390/pharmaceutics14050955 ↗
96. Fluorescent probes as a tool in diagnostic and drug delivery systems10.3390/ph16030381 ↗
97. A p‐hydroxyphenacyl–benzothiazole–chlorambucil conjugate as a real‐time‐monitoring drug‐delivery system assisted by excited‐state intramolecular proton transfer10.1002/anie.201508901 ↗
98. Aggregation-induced emission10.1039/c1cs15113d ↗
99. Molecular mechanism of aggregation‐induced emission
100. Aggregation‐induced emission: new vistas at the aggregate level10.1002/anie.201916729 ↗